COVID-19 PATIENT SURVEY REPORT
Coronavirus has taken the world by storm since the beginning of 2020, and [...]
READ MOREPublication: Clinically meaningful survival benefit in refractory mCRC
May 3, 2019
Colorectal Cancer Canada (CCC) is proud to announce the publication of the paper entitled “What is clinically meaningful survival benefit in refractory metastatic colorectal cancer?” which was the result of a consensus meeting hosted by CCC. We are very thankful for the time and effort that went into producing the article, and hope that it is helpful in addressing issues of equity and transparency in health technology assessment.
